The Effect of Rifampicin on Plasma Glutamyl Transpeptidase, Salicylamide Glucuronide Formation and D-Glucaric Acid Excretion

  • Keti Malaka-Zafiriu
  • G. Katzos
  • J. Sotiriu
  • B. Danielides
  • Chr. Cassimos
Part of the Chemotherapy book series (CT, volume 4)


Urinary D-glucaric acid excretion, salicylamide glucuronide formation and serum γ-glutamyl transpeptidase (γ-GT) activity were measured in 14 normal individuals (Volunteers) and 10 patients suffering from pulmonary tuberculosis before and after the administration of Rifampicin 10 and 30 days respectively.


Urinary Excretion Pulmonary Tuberculosis Oxidative Enzyme Smooth Endoplasmic Reticulum Drug Oxidation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bartels, H., Hank, W., and Vogel, I. (1975). J.Pediatrics 86.298.CrossRefGoogle Scholar
  2. 2.
    Cassimos, Cnr., Malaka-Zafiriu K., Tsiures, J. and Danielides, B (1974). J.Pediatrics, 84. 110.CrossRefGoogle Scholar
  3. 3.
    Cassimos, Chr., Malaka-Zafiriu K., and Tsiures, J., (1974).J. Pediatrics, 84.871.CrossRefGoogle Scholar
  4. 4.
    Davidson, D.C., Mdntosh, W.B. and Ford, J.A. (1974) Clinical Science and Molecular Medicine, 47,279.PubMedGoogle Scholar
  5. 5.
    Edwards, O.M., Courtenay-Evans, R.J., Calley, J.M. Hunter, and Tait, A.D. (1974), Lancet, 11,U59.Google Scholar
  6. 6.
    Hunter, J., Maxwell, J.D., Carrela, W., Stewart, D.A., Williams P. (1971). Lancet 1,572.PubMedCrossRefGoogle Scholar
  7. 7.
    Hunter, J. Personal Communication. London, 1971, 1973.Google Scholar
  8. 8.
    Hunter, J. (1974), J. Roy. Coll.Phycns. 8,163.Google Scholar
  9. 9.
    Levy, G., and Matzuzawa, T. (1967). J. Pharmacolh exp. ther.156, 285.Google Scholar
  10. 10.
    Malaka-Zafiriu, K., Tsiures, J., Danielides, B., and Cassimos Chr. (1973), Helv. Paed. Acta 28, 323.Google Scholar
  11. 11.
    Malaka-Zafiriu, K., Tsiures, J., and Cassimos Chr. (1975), Helv. Paed. Acta 30,1.Google Scholar
  12. 12.
    Marsh, C.A. (1963), Biochem. J. 86,77.PubMedGoogle Scholar
  13. 13.
    Naveh, Y., and Friedman, A. (1973). Arch. Dis. Child. 48,967.Google Scholar
  14. 14.
    Remmer, H., Schoene, B., and Fleischmann, R.A. (1972). Microsomes and drug oxidations, Williams and Wilkins, Baltimore, p224.Google Scholar
  15. 15.
    Rosalki, S.B., Tarlow, D., Rau, D. (l97l), Lancet 11,375.Google Scholar
  16. 16.
    Simmons, C.J., Davis, M., Dordoni, B., and Williams, R. (l974), Clinica Chimica Acta, 51,47.CrossRefGoogle Scholar
  17. 17.
    Szasz, G. (1969), Clin. Chemistry, 15,124.Google Scholar
  18. 18.
    Whitfield, J.B., Moss, D.W., Neale, G., Orme, M., Breckenridge, A. (1973), British Medical Journal l,3l6.Google Scholar

Copyright information

© Plenum Press, New York 1976

Authors and Affiliations

  • Keti Malaka-Zafiriu
    • 1
  • G. Katzos
    • 1
  • J. Sotiriu
    • 1
  • B. Danielides
    • 1
  • Chr. Cassimos
    • 1
  1. 1.Paediatric Clinic, A.H.E.P.A. HospitalUniversity of ThessalonikiThessalonikiGreece

Personalised recommendations